Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Medline Inc. - Class A common stock
(NQ:
MDLN
)
36.21
-0.92 (-2.48%)
Streaming Delayed Price
Updated: 1:35 PM EDT, Jun 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Medline Inc. - Class A common stock
MDLN Investors Have Opportunity to Join Medline Inc. Fraud Investigation with the Schall Law Firm
June 10, 2026
From
Schall Law
Via
GlobeNewswire
Securities Fraud Investigation Into Medline Industries, Inc. (MDLN) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
June 09, 2026
From
Glancy Prongay Wolke & Rotter LLP
Via
Business Wire
Medline Industries, Inc. (MDLN) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
June 09, 2026
From
Law Offices of Howard G. Smith
Via
Business Wire
Medline (NASDAQ:MDLN) Q1 Earnings: Revenue Beats, But Profits Slip on Tariff and Cost Pressures
↗
May 06, 2026
Via
Chartmill
Medline Inc. (NASDAQ:MDLN) Reports Q4 Revenue Beat but EPS Miss Amid Margin Pressure
↗
February 25, 2026
Via
Chartmill
Securities Fraud Investigation Into Medline Industries, Inc. (MDLN) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
June 08, 2026
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Why Symbotic Stock Slumped 21% in May And Just Hit a 2026 Low
↗
June 08, 2026
Is something seriously wrong with the automation expert, or is this a market overreaction and an opportunity to buy?
Via
The Motley Fool
Topics
Economy
Medline Inc. announces closing of upsized secondary offering of Class A common stock
May 28, 2026
From
Medline Inc.
Via
GlobeNewswire
Medline announces participation in upcoming investor conferences
May 27, 2026
From
Medline Inc.
Via
GlobeNewswire
Medline Inc. announces pricing of upsized secondary offering of Class A common stock
May 21, 2026
From
Medline Inc.
Via
GlobeNewswire
Monashee Scales Back Its Bet on Structure Therapeutics
↗
May 20, 2026
This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity.
Via
The Motley Fool
Topics
Regulatory Compliance
Medline Inc. announces launch of secondary offering of Class A common stock
May 20, 2026
From
Medline Inc.
Via
GlobeNewswire
Medline Reports First Quarter 2026 Results
May 06, 2026
From
Medline Inc.
Via
GlobeNewswire
Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters’ option to purchase additional shares
March 10, 2026
From
Medline Inc.
Via
GlobeNewswire
Medline Inc. announces pricing of secondary offering of class A common stock
March 04, 2026
From
Medline Inc.
Via
GlobeNewswire
Medline Inc. announces launch of secondary offering of Class A common stock
March 03, 2026
From
Medline Inc.
Via
GlobeNewswire
Medline Reports Fourth Quarter and Full Year 2025 Results
February 25, 2026
From
Medline Inc.
Via
GlobeNewswire
Medline announces participation in the Barclays 28th Annual Global Healthcare Conference
February 18, 2026
From
Medline Inc.
Via
GlobeNewswire
Symbotic Could Be a Massive Breakout Stock in 2026 After a 150% Surge in 2025
↗
February 05, 2026
Symbotic's big growth moves of 2025 should propel the company to new highs.
Via
The Motley Fool
How the Largest IPO of 2025 Could Be Healthy for Your Portfolio
↗
February 05, 2026
Medline is an appealing investment candidate – it has solid growth, operates in a steady industry, and a storied history.
Via
The Motley Fool
Topics
Economy
Initial Public Offering
Medline to report fourth quarter and full year 2025 results on February 25, 2026
January 28, 2026
From
Medline Inc.
Via
GlobeNewswire
A Fresh IPO That Long-Term Investors Shouldn’t Ignore
↗
January 14, 2026
Via
MarketBeat
Topics
Initial Public Offering
Motley Fool Money: The Most Shocking Stories of 2025
↗
January 05, 2026
Do you remember all of the surprises investors got in 2025? We had tariffs, AI upheaval, and even gold having a great year.
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
World Trade
The 2025 IPO Market Review: A Year of Selective Recovery and the 2026 Outlook
December 31, 2025
As the final bell rings on 2025, the U.S. initial public offering (IPO) market has emerged from its multi-year hibernation, not with a frantic sprint, but with a calculated and selective stride. After...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Initial Public Offering
Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference
December 30, 2025
From
Medline Inc.
Via
GlobeNewswire
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 18, 2025
From
Medline Inc.
Via
GlobeNewswire
Medline’s Blockbuster IPO Ignites Market Optimism: The Largest Debut Since 2021
December 18, 2025
In a stunning return to the public stage, Medline Industries (Nasdaq: MDLN) successfully executed the largest initial public offering (IPO) in the United States since 2021, pricing its shares at the...
Via
MarketMinute
Topics
Economy
Initial Public Offering
World Trade
Medline Industries (MDLN) Deep-Dive: The $54 Billion Return of a Healthcare Titan
December 18, 2025
The global healthcare landscape shifted decisively on December 16, 2025, with the public market return of Medline Industries (Nasdaq: MDLN). After four years under the stewardship of a private equity...
Via
PredictStreet
Topics
Artificial Intelligence
Earnings
Economy
Medline Stock Soars In Debut As Medical Supply Giant Seals 2025’s Biggest IPO
↗
December 17, 2025
The company's first day on the market underscored strong investor demand for scaled, profitable issuers as the U.S. IPO pipeline shows strength.
Via
Stocktwits
Topics
Initial Public Offering
Supply Chain
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
